Fulminant hepatic failure secondary to hydroxychloroquine.
Institute of Liver Studies, King's College Hospital, London.
Hydroxychloroquine is widely used in rheumatological disease but hepatic side effects have not been reported previously. Two cases are described of fulminant hepatic failure developing after the start of hydroxychloroquine treatment for a chronic rheumatological disorder. In both cases the symptoms of liver disease developed within two weeks of starting hydroxychloroquine and rapidly progressed to fulminant hepatic failure and in neither case was there any pre-existing liver disease. One patient had emergency orthotopic liver transplantation and the other died before a donor organ became available.
This article has been cited by other articles:
-
Leckie, M. J., Rees, R. G.
(2002). Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis. Rheumatology (Oxford)
41: 473-474
[Full Text] -
Sontheimer, R. D.
(2000). Questions Answered and a $1 Million Question Raised Concerning Lupus Erythematosus Tumidus: Is Routine Laboratory Surveillance Testing During Treatment With Hydroxychloroquine for Skin Disease Really Necessary?. Arch Dermatol
136: 1044-1049
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
